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Abstract
Snake bite leads to medical emergencies and sometimes death. It is clinically managed by 
administration of monovalent/polyvalent antisera and it exhibit early or late adverse reactions 
and sometimes these adverse effects lead to fatalities.
snake bite by the traditional healers; however, there is paucity of scientific data 
this claim. To examine the anti-snake venom activities of ethanolic and aqueous extracts of 
Cassia hirsute against Indian cobra (Naja naja
activities of ethanolic and aqueous extracts of 
naja) venom induced toxicity was studied in mice, rats and sheep by 
as follows: Phospholipase A2 induced hemolysis on sheep RBC,
anticoagulation[Coagulation activity], Naja naja
activity against lethality induced by Naja naja
induced odema, liver function of venomized rats.
as 2mg/kg and both ACH and ECH shown significant neutralization of 
induced lethality. Both extracts inhibited phospholipase A
RBC's and showed a high significant reductio
venom with 80.51% inhibition of anti-coagulation of ECH at 350 µg and 79.84% of ACH at 
300 µg. ECH and ACH 300, 600 and 900 mg/kg shows significant (
bleeding time also. These findings suggest a potential antivenom role of 
against Naja naja venom. 
Copyright@2015 STAR Journal
INTRODUCTION 
Snake bite is an occupational hazard in tropical and 
sub-tropical countries like India (Ahmed et al
estimated that 2.5 million people get envenomed each 
year on a global basis (Chippaux, 1998 and Sharma 
2008) and approximately 35,000- 50,000 deaths are 
reported in India per annum (Warrell, 1999 and 
Dhananjaya, 2011). An accurate measure of snake bite 
envenoming remains elusive as victims approach 
traditional healers for aid and treatment. Snake 
envenomation leads to many pathophysiological 
conditions like inflammation, hemorrhage, necrosis, 
nephrotoxicity, cardio toxicity and finally death (Theakston 
and Reid, 1983). The most common poisonous snakes 
found in India are Spectacled cobra (Naja naja
(Bungarus caeruleus), Russell’s viper (Daboia russelli
and Saw-scaled viper (Echiscarinatus). The cobra and 
krait belong to Elapidae family and their venom is 
considered to have predominantly neurotoxic effects, the
affect the victim’s central nervous system and cause heart 
failure. Their venom possesses several proteins, including 
cardiotoxins, neurotoxins and phospholipase A
responsible for their toxicity. Russell’s viper and saw
scaled viper belong to Viperidae and are histotoxic 
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2, that are 
-
(Bawaskar, 2001) hemorrhagic, therefore they provoke 
hemorrhagic manifestations that include epistaxis and 
cardiac manifestations such as myocarditis and cardiac 
failure (Meenatchisundaram and Michael, 2009). 
naja (Indian Cobra) is commonly found in most of the 
Indian states and its bite leads to several deaths per year. 
Antivenom use against snake bites is lacking in the rural 
areas of Asian countries due to its cost and special 
storage conditions that are required for kee
antivenoms. Antiserum; being the only therapeutic agent, 
its development from animal source is time consuming 
and expensive. Availability of monovalent/polyvalent 
antiserum in rural areas is very less due to its high cost 
and special storage requirements. Additionally there are 
few hospital centers in rural areas that can manage 
snakebite cases. To overcome these drawbacks, there is 
a need to search, develop new affordable and safe 
antidote against snakebites. 
 
The World Health Organization estimates that 80% of 
the world’s population depends on traditional medicine for 
their primary health care needs. As long as man can 
remember, plants/plant materials have been used 
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worldwide in traditional medicine for the treatment of 
different diseases. It is estimated that even today 
approximately seventy percent of the world population rely 
on medicinal plants as their primary source of medicines 
(McChesney, 1995). Over the years, many attempts have 
been made for the development of snake venom 
antagonists especially from plant sources in spite of the 
existence of antiserum. Many Indian medicinal 
plants/plant materials are recommended for the treatment 
of snakebite (Chopra, Nayar and Chopra, 1956 and 
Nazimudeen, Ramaswamy and Kameswaran, 1978). 
 
Cassia hirsute Linn. Plant (Holm et al., 1979 and Irwin 
and Barneby, 1982) belongs to the family 
Caesalpiniaceae and is commonly called as stinking 
cassia and hairy senna. It is a native of tropical America 
and now distributed in Malaysia, Indo-China, Thailand, 
Asian and African tropics, Laos, Java, Brazil, California, 
New Mexico and India. Chakma communities of 
Bangladesh use the leaves against snakebite (Roy, 
2008). Leaf and root extract is used by the tribal people of 
Chittagong hill tracts of Bangladesh. Extracts are also 
used to prepare juice and paste. Juice is taken orally and 
paste is applied locally (Biswas et al., 2010).
 
Also 
traditionally it is widely used for stomach troubles, 
dysentery, abscesses, rheumatism, haematuria, fever and 
other diseases. Powdered seeds are used to massage the 
teeth and gums to protect from plaque and cavities, as 
antimicrobial, in treatment of herpes and a medicine for 
Parkinson’s disease and screening was done on 
antioxidant activity (Vellingiri, Aruna and Hans, 2011) 
antibacterial activity (Tapas et al., 2012) and 
hepatoprotective activity (Parker and Okwesili, 2010). 
 
Keeping in view the above background and 
biopotential of plants, present investigation was directed 
towards evaluating the anti-snake venom activities of 
ethanol and aqueous extract of Cassia hirsute against 
Indian cobra (Naja naja) venom induced toxicity. During a 
field trip to Pathankot (Punjab, India), traditional healers 
shared information that root extracts have been in use for 
snakebite case from generation in their family. 
 
MATERIALS AND METHOD 
Collection of Plant and Preparation of Extracts 
The plant Cassia hirsute were collected from forest 
near Nelmangala, Dist. Tumkur, State Karnataka and was 
identified by Dr. M.D. Rajanna, Dept of Botany, GKVK. 
University of agriculture science, Bangalore. A voucher 
specimen is been deposited at Museum, Mallige College 
of Pharmacy, Bangaluru. The roots were cleaned and air 
dried then subjected to coarse powdering and passed 
through a sieve # 44 to get uniform powder size. The 
collected powder was successively extracted with 
petroleum ether to defat and then by ethanol for 24 hr by 
using soxhlet apparatus and followed by water using 
maceration.  After the extraction, solvents was distilled off 
to get concentrated residue and completely dried by 
lyophilization and stored in air tight container under 
refrigeration (Shalavadi et al., 2013).
 
ECH=Ethanol extract 




The Wistar rats of either sex (230-260 gm) and Swiss 
albino mice were used. The animals were housed at room 
temperature (22-28 ºC) with 65±10% relative humidity for 
12 hr dark and light cycle and given standard laboratory 
feed (Amruth, Sangli, Maharashtra) and water ad libitum. 
The study was approved and conducted as per the norms 
of the Institutional Animal Ethics Committee. 
 
Chemicals 
Tween-80 (Rankem, New Delhi, India), CK Nac kit. 
(Span Diagnostic Ltd., Surat, India), Naja naja venom 
(Haffkines Institute, Mumbai), Phenobarbitone Sodium, 
Human Citrated Plasma (K.R. Hospital, Bangalore), 
Sheep Blood was collected from Srinagar, Bangalore and 
Phosphate Buffer Solution (PBS) of pH 7.2. All the other 
solvents and chemicals used for extraction and 
phytochemical investigation were of analytical grade. 
 
Preparation of Venom Sample 
The lyophilized Snake Venom of Naja naja was 
preserved in a desiccator at4 ̊C. It was dissolved in PBS 
of pH 7.2 for further use. 
 
LD50 and Minimum Lethal Dose (MLD) of Naja naja 
Venom 
The  median  Lethal  dose  (LD50)  and minimum 
lethal dose (MLD) of  Naja naja  venom  was  assayed  by 
injecting different  concentrations  of  venom  in  0.2  ml  
normal  saline  into  the peritoneum of Wistar albino rats. 
 
Neutralization Activity of Cassia hirsute against 
Lethality Induced by Naja naja Venom (2mg/kg) in 
Rats 
The ability of the ethanol and aqueous extract of 
Cassia hirsute to neutralize lethal toxicity of venom was 
assessed by in-vivo neutralization test. In in-vivo method 
the plant extracts was administered to animals 1 hour 
prior to challenge with MLD dose of venom to animal. In-
vivo neutralization was performed in rats (n=6). The rats 
were administered with ethanol and aqueous extracts 
(50,100, 200, 300, 400 and 500 mg/kg) of Cassia hirsute 
through oral route one hour prior to administration of 2 
mg/kg of MLD of venom by intraperitoneal route; all the 






Phospholipase A2 activity was assessed by indirect 
hemolytic activity assay on agarose-erythrocyte-egg yolk 
gel plate as described by Gutierrez et al. (1988). 300 µl of 
packed sheep erythrocytes washed four times with saline 
solution, 300 µl of 1:3 egg yolk solution in saline solution 
and 250 µl of 0.01 M CaCl2 solution were added to 25 ml 
of 1% (w/v) of agar at 50ºC dissolved in PBS pH 7.2. The 
mixture was applied to Petri dish and allowed to gel. 
Then, 3 mm diameter wells were made and filled with 15 
µl venom samples. After 20 hr of incubation at 37ºC, the 
diameters of hemolytic halos were measured. To 
determine the minimum hemolytic dose (MHD) of Naja 
naja venom, 15 µl of solutions containing different 
amounts of venom concentration (from 1 to 50 µg), were 
applied into the wells. Control wells contained 15 µl of 
Phosphate buffer of pH 7.2. After 20 h of incubation at 
37ºC, the diameters of hemolytic halos were measured. 
The minimum hemolytic dose (MHD) was defined as the 
amount of venom that induced a hemolytic halo of 11-mm 
diameter (Marunak et al., 2007 and Meenatchisundaram, 
2008). 
 
Neutralization of phospholipase A2 activity (indirect 
hemolytic activity) by ethanolic and aqueous extracts of 
Cassia hirsute was performed by neutralizing venom 
mixture containing constant amount of [15µg (1 MHD)] 
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venom incubated with different amounts of ECH and ACH 
(6.25-800 µg) for 30 min at 37°C. The 15µl aliquots of the 
mixtures (venom + extracts) were added to wells in 
agarose-egg yolk-sheep-erythrocytes gels, plates were 
incubated at 37°C for 20 h. Control samples [15µg (1 
MHD)] contained venom without extract. Plates were 
incubated at 37°C for 20 hr. Neutralization was expressed 
as the % Inhibition that reduced 50% the diameter of the 





The coagulation activity of the ECH and ACH against 
the anticoagulant response caused byNaja naja venom by 
described by Theakston et al. (1983).
 
Assay was started 
by finding minimum coagulation dose of plasma (MCD-P) 
of venom and assayed by taking various concentration of 
venom (1-150 µg), dissolved in 100 µl of PBS of pH 7.2 
and to this 300 µl of human citrated plasma was added 
which was collected from Blood Bank of K.R.Hospital, 
Bangalore, India; to this 100µl of 0.25M CaCl2 was added 
and the clotting time was observed every 15 sec by gentle 
tilting until coagulation occurred. Plasma incubated with 
PBS alone served as control. MCD-P was defined as the 
least amount of venom that clots plasma in 60 sec at 
37°C (Karlsson and Pongsawasdi, 1980). 
 
The neutralization of anticoagulation activity of ECH 
and ACH induced by Naja naja venom was done by taking 
constant amount of venom (2 MCD-P) which was mixed 
with various concentrations of ECH (50-350µg) and ACH 
(50-300 µg). The mixtures were incubated for 30 min at 
37°C and then 100µl of mixture was added to 300 µl of 
citrated plasma, the plasma was recalcified with the 
addition of 100 µl of 0.25 M CaCl2 and the clotting times 
were recorded by gentle tilting at every 15 sec till 
coagulation occurred. 
  
Effect of ECH and ACH on Naja naja Induced Bleeding
 
Bleeding time test was performed using male Swiss 
albino mice weighing 18-20gm. The mice were grouped in 
8 groups, each group contained 6 animals and group 1 
received vehicle orally, group 2 received vehicle orally 
and Naja naja venom LD50 dose by i.v route and group 3 
to 8 received required doses of ECH (300, 600 and 900 
mg/kg) and ACH (300, 600 and 900 mg/kg) by oral route 
one hour before the administration of Naja naja venom 
(i.v. route). After one hour all the animals were 
anaesthetized with Ketamine (45 mg/kg i.p. route). A 
wound was made on the tail vein of the mouse by surgical 
razor at 5 cm from the tip. The blood was absorbed on 
Whatman no.1 filter paper at every 15 sec interval till no 
blood stain was appeared on the filter paper then total 
bleeding time was recorded (Karasudani et al., 1996). 
 
Edema-forming Activity 
The Minimum edema-forming dose (MED) of Naja naja 
venom was determined by the method of Camey et al. 
(2002).The Minimum edema-forming dose was defined as 
the least amount of venom which when injected 
subcutaneously into rat footpad results in 30% edema 
within 6 hours of venom injection. The volume of each 
footpad was measured every 60 min after venom injection 
with a digital plethysmometer. The rats were grouped in 8 
groups, each group containing 6 animals and group 1 
received vehicle orally, group 2 received vehicle orally 
and intraplantar route Naja naja venom (6µg/100µl) and 
group 3 to 8 received required doses of ECH (100, 200 
and 300 mg/kg) and ACH (100, 200 and 300 mg/kg) by 
oral route one hour prior to the administration of Naja naja 
venom by intraplantar route. One hour after venom 
injection change in the paw volume was recorded every 
hour till completion of 5 hours.  
 
Statistical Analysis 
All the data are expressed in mean ± SEM. The 
significance of differences in means between control and 
treated animals for different parameters was determined 
by one-way analysis of variance (ANOVA) followed by 
Dunnett’s multiple comparison test. The minimum level of 
significance was fixed at p<0.05. 
 
RESULTS 
LD50 and MLD of Naja naja Venom 
The  table  1  reveals that  the  results  of  lethality  
tests  on  Naja naja venom  for  determination  of  median  
lethal  dose  (LD50)  and  the minimum  lethal  dose  
(MLD)  after  intraperitoneal  injection  in  rats.  The 
median lethal dose (LD50) of the venom was 1.5mg/kg 
and minimum lethal dose (MLD) was found as 2mg/kg. 
 







No. of deaths/ 
No. of rats used 




1 - 0/6 0 
2 0.5 0/6 0 
3 1 1/6 16.67 
4 1.5 3/6 50 
5 2 6/6 100 
6 2.5 6/6 100 
 
Neutralization Activity of Cassia hirsute against 
Lethality Induced by Naja naja Venom (2mg/kg) in 
Rats 
Naja naja venom induced lethality was significantly 
antagonized by both ECH and ACH. Both extracts at 
400mg/kg dose shown 66.67% survival and effective  
dose  50%  (ED50)  of ECH and ACH after intraperitoneal  
injection  in venom pretreated  rats  were found  to  be 
200mg/kg and 300mg/kg body  weight respectively and 
results were summarized in table 2. 
 
Table 2: In vivo Neutralization activity of Cassia hirsute 
against lethality induced by Naja naja venom 







(within 24h of venom 
+extract administration 






0 6/6 0 
50 6/6 0 
100 5/6 16.67 
200 4/6 33.33 
300 3/6 50 
400 2/6 66.67 
500 2/6 66.67 
ACH 
0 6/6 0 
50 6/6 0 
100 6/6 0 
200 5/6 16.67 
300 3/6 50 
400 2/6 66.67 
500 2/6 66.67 
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Phospholipase A2 Activity 
In present study Naja naja venom was able to produce 
hemolytic haloes in agarose-sheep erythrocytes gels 
because venom have the enzyme phospholipase A2 that 
has the ability to lyse sheep RBC's. About 15 µg of Naja 
naja venom produced 11.26 mm diameter haemolytic 
haloes (Table 3) thus 15µg Naja naja venom was taken 
as minimum hemolytic dose (MHD). Both ECH and ACH 
inhibited phospholipase A2 dependent haemolysis of 
sheep RBC's induced by Naja naja venom in a dose 
dependent manner. From table 4 and 5, it was found that 
800µg of ECH inhibited haemolysis by 56.66% with 
4.88mm haloes but with ACH it was 82.24% with 2mm 
haloes.  
 
Table 3: Phospholipase A2 [Naja naja venom] induced 
hemolysis on sheep RBC 
 









Table 4: Effect of ECH and ACH on Phospholipase A2 
(Naja naja venom) induced hemolysis of sheep RBC 
 






6.25 10.92 3.02 
12.5 10.02 11.01 
25 9.48 15.81 
50 8.98 20.25 
100 8.32 26.11 
200 7.04 37.48 
400 6.82 39.43 
800 4.88 56.66 
Table 5: Effect of ACH on Phospholipase A2 [Naja naja 
venom] induced hemolysis on sheep RBC 
 






6.25 10.02 11.01 
12.5 9.80 12.97 
25 8.62 23.45 
50 7.36 34.64 
100 6.92 38.54 
200 5.02 55.42 
400 4.12 63.41 
800 2.00 82.24 
 
Coagulation Activity 
Naja naja venom was found to be anti-coagulant in 
nature hence; the coagulation activity ECH and ACH was 
performed using the human plasma. Minimum coagulation 
dose of plasma (MCD-P) of Naja naja venom was found 
to be 60 µg. To test the coagulant activity of the ECH and 
ACH the 2 X MCD-P was used i.e., 120 µg of venom. 120 
µg was kept constant and varying doses of extracts i.e 
ECH (50-350µg) and ACH (50-300µg) were used. In 
control (venom treated) the coagulation time was found to 
be 121.5±2.172sec which was increased significantly 
(P<0.001) as compared with normal coagulation time was 
produced (Plasma + PBS+ CaCl2) at a time period of 
23.83±0.307 sec. In contrast, the ECH (100, 150, 200, 
250, 300 and 350 µg) and ACH (100, 150, 200, 250 and 
300 µg) treated showed a high significant reduction 
(P<0.001) in the anti-coagulant activity of venom with 
80.51% inhibition of anti-coagulation of ECH at 350 µg 
and 79.84% of ACH at 300 µg and results were 
summarized in table 6. 
 






dose of ERS in µg 
No. of  
folds 
Formation of clot 
Mean ± SEM 
(Seconds) 
% Inhibition of anti-coagulation 
{Formation of clot by venom[sec] -  
formation of clot by extract [sec] ÷ 
Formation of clot by venom[sec]} X 100 









50 113.5±1.455** 6.58 
100 96.33±1.333*** 20.71 
150 73.67±1.282*** 39.36 
200 56.67±1.978*** 53.35 
250 29.83±1.400*** 75.44 
300 27.50±0.922*** 77.36 









100 89.17±2.301*** 26.6 
150 63.50±1.335*** 47.73 
200 38.83±1.797*** 68.04 
250 25.33±1.256*** 79.15 
300 24.50±1.176*** 79.84 
 
Effect of ECH and ACH on Naja naja Induced Bleeding 
Table 7 reveals that the bleeding time significantly 
(P<0.001) increased in venom treated group i.e. in first 
hour it was 207.5±4.61 sec as compared with normal 
group. In contrast the ECH 300, 600 and 900 mg/kg 
shows significant (P<0.001) decrease in bleeding time 
162.5±4.610, 145.0±3.162 and 137.5±4.610 sec 
respectively in first hour as compared with venom treated 
group. Similarly ACH 300, 600 and 900 mg/kg also shown 
significant (P<0.001) decrease in bleeding time 
175.0±3.162, 152.5±4.610 and 152.5±4.610 sec 
respectively as compared to venom treated group. 
Table 7: Effect of ECH on Naja naja induced bleeding 
 




























1 102.5±6.021 207.5±4.610a 162.5±4.610*** 21.68 145.0±3.162*** 30.12 137.5±4.610*** 33.73 
2 100.0±5.000 202.5±3.354a 152.5±2.500*** 24.69 140.0±3.162*** 30.86 130.0±3.162*** 35.8 
3 97.50±5.123 185.0±6.325a 155.0±3.162*** 16.21 142.5±3.354*** 22.97 135.0±3.873*** 27.07 
4 95.00±3.162 185.0±6.325a 152.5±2.500*** 17.56 145.0±5.000*** 21.62 132.5±2.500*** 28.37 




Anti-inflammatory activity of ECH and ACH against 
venom induced paw thickness was carried out in rats. In 
edema forming activity, the rats injected with Naja naja 
venom showed increase in paw thickness. About 6 µg of 
venom induced more than 30% edema formation within 3 
hrs which is considered as 100% activity and it was 
considered as MED. The venom treated control animals 
shown significant (P<0.001) increase in paw edema in 
2
nd
hr and onwards as compared with normal group. In 
contrast animals pre-treated with ECH and ACH (100, 200 
and 300 mg/kg) one hour before challenging with MED of 
venom showed a highly significant (P<0.001) decrease in 






hr as compared with control 
treated animals. The 50% inhibition was shown by both 
extracts at 2
nd
hr and result was summarized in table 8.  
 
 


























1 102.5±6.021 207.5±4.610a 175.0±3.162*** 15.66 152.5±4.610*** 26.50 152.5±4.610*** 26.50 
2 100.0±5.000 202.5±3.354a 167.5±4.610*** 17.28 147.5±2.500*** 27.16 140.0±5.000*** 30.86 
3 97.50±5.123 185.0±6.325a 170.0±3.162 8.10 152.5±4.610*** 17.56 142.5±6.423*** 22.97 
4 95.00±3.162 185.0±6.325a 167.5±2.500* 9.45 150.0±3.873*** 18.91 142.5±6.423*** 22.97 
% Inhibition of bleeding time= {[Bleeding time of Venom control- Bleeding time of Treated group]÷ Bleeding time of Venom control} X 100 
 
 
















































































































































Normal 0.035±0.002 0.052±0.005 - 0.032±0.0008 - 0.0315±0.0052 - 0.030±0.0047 - 0.027±0.00445 - 








































Snake envenomation causes pathological changes in 
the victims, ultimately leading to death in the absence of 
proper medical aid. Several pharmacological actions 
exhibited by the venoms are due to the combined action 
of various site-specific toxins and hydrolytic enzymes, 
whose concentrations and potencies are known to vary, 
depending upon various factors (Chippaux, Williams and 
White, 1991) thus complicating the management of snake 
bite. Many Indian medicinal plants are recommended for 
the treatment of snakebites (Alam and Gomes, 2003). 
Both ethanol and aqueous extracts of Cassia hirsute 
significantly inhibits the lethality induced by the Naja naja 
venom. The ACH contains glycosides which may be 
responsible of antivenom activity as it is mentioned in 
literature that glycosides are found widely in anti-snake 
venom plants and provide nearly 20% protection against 
snake venom (Argiolas and Pisano, 1983) it also contains 
β-sitosterols which is the most abundant of the 
phytosterols which might have neutralized toxic enzymes 
of the Naja naja venom. The obtained results are in-line 
with literature that suggests that plant Pluchea indica 
containing β-sitosterols neutralizes the cobra venoms 
toxic reactions (Gomes et al., 2007). 
 
Rupturing of blood capillaries of tissues was necessary 
for the release of haemoglobin and it may be contributed 
by phospholipid hydrolysis and protease activity present in 
Naja naja PLA2 (Datta and Bhattacharyya, 1999). Some 
constituents of plants have the ability to bind proteins and 
inhibit their enzymatic activity as well as the catalytic 
activity of snake venoms PLA2 (Gowda, 1997 and Melo 
and Ownby, 1999). As Cassia hirsute contains tannins as 
well as β-sitosterols, glycoside which have the ability to 
bind with the proteins that produces toxic effects, in this 
study the different concentrations of ECH and ACH were 
evaluated for their activity against PLA2. Both ECH and 
ACH displayed significant inhibition of PLA2 activity. 
 
Increase in concentration of Naja naja venom prolongs 
the clotting time of human plasma. The anticoagulant 
effect of PLA2 from Naja naja venom is due to enzymatic 
degradation of phospholipids necessary for the adherence 
and activation of coagulation protein factors. Incubation of 
ECH and ACH is able to prevent the anticoagulation 
action by preponing coagulation time against Naja naja 
venom. The neutralization of anticoagulation might be due 
to active component of Cassia hirsute. Naja naja venom 
showed more prolonged bleeding time from that of the 
heparin, which indicates that the Naja naja venom 
contains potent anti-coagulant property. The ECH and 
ACH have shown high significant activity as compared to 
control group. 
 
As the main component of the Naja naja venom is 
PLA2 which also has characteristic activity of producing 
edema, development of edema is a common feature of 
the coetaneous inflammatory response and is dependent 
on a synergism between endogenous mediators that 
increase vascular permeability and those that increase 
blood flow (Ketelhut et al., 2003).
 
Both extracts showed 
significant reduction in paw thickness as compared to 
venom control group. This is due to the presence of 






In conclusion, these findings suggest a potential 
antivenom role of Cassia hirsute against Naja naja 
venom. Further studies are required to pursue the 
interesting lead emerging from the present results to 
exploit the full therapeutic potential of Cassia hirsute, as 
antivenom. 
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